Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes.

European journal of pharmacology

Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H.
PMID: 34906548
Eur J Pharmacol. 2022 Feb 05;916:174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11.

AIMS: Ivabradine (IVA) reduces heart rate (HR) by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in sinoatrial node. Studies suggest that IVA has other beneficial effects on cardiovascular system that are not related to its effect on HR such as...

Cite
Kara Z, Güven B, Onay Besikci A, et al. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2021;916:174551doi: 10.1016/j.ejphar.2021.174551.
Kara, Z., Güven, B., Onay Besikci, A., Yıldırım, N., & Altunay, H. (2022). Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. European journal of pharmacology, 916174551. https://doi.org/10.1016/j.ejphar.2021.174551
Kara, Zümra, et al. "Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes." European journal of pharmacology vol. 916 (2022): 174551. doi: https://doi.org/10.1016/j.ejphar.2021.174551
Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2022 Feb 05;916:174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11. PMID: 34906548.
Copy Download .nbib Format: NLM
Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes.

European journal of pharmacology

Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H.
PMID: 34906548
Eur J Pharmacol. 2021 Dec 11;174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11.

AIMS: Ivabradine (IVA) reduces heart rate (HR) by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in sinoatrial node. Studies suggest that IVA has other beneficial effects on cardiovascular system that are not related to its effect on HR such as...

Cite
Kara Z, Güven B, Onay Besikci A, et al. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2021;174551doi: 10.1016/j.ejphar.2021.174551.
Kara, Z., Güven, B., Onay Besikci, A., Yıldırım, N., & Altunay, H. (2021). Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. European journal of pharmacology, 174551. https://doi.org/10.1016/j.ejphar.2021.174551
Kara, Zümra, et al. "Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes." European journal of pharmacology vol. (2021): 174551. doi: https://doi.org/10.1016/j.ejphar.2021.174551
Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2021 Dec 11;174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11. PMID: 34906548.
Copy Download .nbib Format: NLM
Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors.

Turkish journal of pharmaceutical sciences

Demirel S, Ayhan Kilcigil G, Kara Z, Güven B, Onay Beşikci A.
PMID: 32454626
Turk J Pharm Sci. 2017 Dec;14(3):285-289. doi: 10.4274/tjps.24008. Epub 2017 Nov 20.

OBJECTIVES: In this study, some novel 2-(2-phenyl)-1MATERIALS AND METHODS: Compounds 1-12 were obtained by condensing 2-(2-phenyl)-1RESULTS: Following the structure elucidation, epidermal growth factor receptor kinase inhibitor activity was measured. The ADP-GloCONCLUSION: Almost all of the compounds' kinase inhibitor activities...

Cite
Demirel S, Ayhan Kilcigil G, Kara Z, et al. Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors. Turk J Pharm Sci. 2017;14(3):285-289doi: 10.4274/tjps.24008.
Demirel, S., Ayhan Kilcigil, G., Kara, Z., Güven, B., & Onay Beşikci, A. (2017). Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors. Turkish journal of pharmaceutical sciences, 14(3), 285-289. https://doi.org/10.4274/tjps.24008
Demirel, Serkan, et al. "Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors." Turkish journal of pharmaceutical sciences vol. 14,3 (2017): 285-289. doi: https://doi.org/10.4274/tjps.24008
Demirel S, Ayhan Kilcigil G, Kara Z, Güven B, Onay Beşikci A. Synthesis and Pharmacologic Evaluation of Some Benzimidazole Acetohydrazide Derivatives as EGFR Inhibitors. Turk J Pharm Sci. 2017 Dec;14(3):285-289. doi: 10.4274/tjps.24008. Epub 2017 Nov 20. PMID: 32454626; PMCID: PMC7227932.
Copy Download .nbib Format: NLM
Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes.

European journal of pharmacology

Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H.
PMID: 34906548
Eur J Pharmacol. 2021 Dec 11;174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11.

AIMS: Ivabradine (IVA) reduces heart rate (HR) by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels in sinoatrial node. Studies suggest that IVA has other beneficial effects on cardiovascular system that are not related to its effect on HR such as...

Cite
Kara Z, Güven B, Onay Besikci A, et al. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2021;174551doi: 10.1016/j.ejphar.2021.174551.
Kara, Z., Güven, B., Onay Besikci, A., Yıldırım, N., & Altunay, H. (2021). Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. European journal of pharmacology, 174551. https://doi.org/10.1016/j.ejphar.2021.174551
Kara, Zümra, et al. "Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes." European journal of pharmacology vol. (2021): 174551. doi: https://doi.org/10.1016/j.ejphar.2021.174551
Kara Z, Güven B, Onay Besikci A, Yıldırım N, Altunay H. Pleiotropic vascular effects of ivabradine in streptozotocin-induced diabetes. Eur J Pharmacol. 2021 Dec 11;174551. doi: 10.1016/j.ejphar.2021.174551. Epub 2021 Dec 11. PMID: 34906548.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries